Upgrade to SI Premium - Free Trial

Innoviva (INVA) Reiterated at Overweight by Cantor Fitzgerald After Webinars on New Segment

April 8, 2026 7:30 AM
Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $32.00 price target on Innoviva Inc. (NASDAQ: INVA).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments